Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
US6818447B1 · kind B1 · utility
32Cited by
5References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 10, 2000 |
| Grant date | Nov 16, 2004 |
| Priority date | — |
| Expiry date | Mar 18, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/322
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to nucleic acid molecules which modulate the synthesis, expression and/or stability of an mRNA encoding one or more receptors of vascular endothelial growth factor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.